
    
      No medical therapy is currently available for the long-term treatment of abnormal uterine
      bleeding associated with uterine fibroids. Asoprisnil (10 mg and 25mg) is being evaluated in
      a Phase 3 program to establish long term safety and effectiveness and therefore provide women
      with a medical alternative to surgery.
    
  